These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11729932)

  • 21. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels.
    De Boer P; Enrico P; Wright J; Wise LD; Timmerman W; Moor E; Dijkstra D; Wikström HV; Westerink BH
    Brain Res; 1997 May; 758(1-2):83-91. PubMed ID: 9203536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist.
    Griffon N; Pilon C; Schwartz JC; Sokoloff P
    Eur J Pharmacol; 1995 Aug; 282(1-3):R3-4. PubMed ID: 7498261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.
    Mukherjee J; Narayanan TK; Christian BT; Shi B; Dunigan KA; Mantil J
    Synapse; 2000 Jul; 37(1):64-70. PubMed ID: 10842352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.
    Nakajima S; Patterson RL
    Brain Res; 1997 Jun; 760(1-2):74-9. PubMed ID: 9237520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
    Hall DA; Strange PG
    Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum.
    Gilbert DB; Millar J; Cooper SJ
    Brain Res; 1995 May; 681(1-2):1-7. PubMed ID: 7552265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography studies on some neurotransmitter receptor systems with 6R-tetrahydrobiopterin pretreatment.
    Watanabe Y; Tani Y; Kanai T; Hartvig P; Inoue O; Andersson J; Lilja A; Långström B
    Adv Exp Med Biol; 1993; 338():321-6. PubMed ID: 8304129
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.
    Cooper SJ; Rusk IN; Barber DJ
    Physiol Behav; 1989 Jun; 45(6):1263-6. PubMed ID: 2573095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    Br J Pharmacol; 2001 Sep; 134(1):88-97. PubMed ID: 11522600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
    Yamada S; Yokoo H; Nishi S
    Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gz proteins are functionally coupled to dopamine D2-like receptors in vivo.
    Leck KJ; Blaha CD; Matthaei KI; Forster GL; Holgate J; Hendry IA
    Neuropharmacology; 2006 Sep; 51(3):597-605. PubMed ID: 16814816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C; Cummins R; Gnoffo Z; Kew JN
    Eur J Pharmacol; 2006 Mar; 534(1-3):108-14. PubMed ID: 16490190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia.
    Lahti AC; Weiler M; Carlsson A; Tamminga CA
    J Neural Transm (Vienna); 1998; 105(6-7):719-34. PubMed ID: 9826114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.